Bulletin
Investor Alert

Cyclo Therapeutics Inc.

NAS: CYTH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 7:54 p.m.

/zigman2/quotes/207006339/composite

$

2.14

Change

+0.16 +8.08%

Volume

Volume 12

Quotes are delayed by 20 min

/zigman2/quotes/207006339/composite

Previous close

$ 2.05

$ 1.98

Change

-0.07 -3.41%

Day low

Day high

$1.95

$2.10

Open

52 week low

52 week high

$1.88

$13.00

Open

Annual Financials for Cyclo Therapeutics Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Net Income before Extraordinaries (3.83M)(4.26M)(7.53M)(8.94M)(14.29M)
Depreciation, Depletion & Amortization 9,27110,1245,68112,76316,827
Depreciation and Depletion 9,27110,1245,68112,76316,827
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit -----
Deferred Taxes -----
Investment Tax Credit -----
Other Funds 121,36395,570449,964271,308492,803
Funds from Operations (3.7M)(4.15M)(7.08M)(8.66M)(13.78M)
Extraordinaries -----
Changes in Working Capital 639,944960,899487,401117,347(1.23M)
Receivables 32,807(23,184)(63,385)72,412(444,023)
Accounts Payable 593,428898,8821.12M144,998408,246
Other Assets/Liabilities (6,967)42,661(728,883)(104,784)(1.2M)
Net Operating Cash Flow (3.06M)(3.19M)(6.59M)(8.54M)(15.01M)

Investing Activities

20172018201920202021 5-year trend
Capital Expenditures (6,856)(2,959)(1,324)(53,127)(22,500)
Capital Expenditures (Fixed Assets) (6,856)(2,959)(1,324)(53,127)(22,500)
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses 4,650----
Purchase/Sale of Investments -----
Purchase of Investments -----
Sale/Maturity of Investments -----
Other Uses -----
Other Sources 34,40935,89937,45639,07937,322
Net Investing Cash Flow 32,20332,94036,132(14,048)14,822

Financing Activities

20172018201920202021 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 3.34M4.1M7.12M18.46M18.76M
Repurchase of Common & Preferred Stk. -----
Sale of Common & Preferred Stock 3.34M4.1M7.12M18.46M18.76M
Proceeds from Stock Options 3.34M4.1M7.12M18.46M-
Other Proceeds from Sale of Stock ----18.76M
Issuance/Reduction of Debt, Net ---158,524(6,778)
Change in Current Debt -----
Change in Long-Term Debt ---158,524-
Issuance of Long-Term Debt ---158,524-
Reduction in Long-Term Debt ----(6,778)
Other Funds -----
Other Uses -----
Other Sources -----
Net Financing Cash Flow 3.34M4.1M7.12M18.62M18.76M
Exchange Rate Effect -----
Miscellaneous Funds -----
Net Change in Cash 310,776946,439566,30710.06M3.77M
Free Cash Flow (3.07M)(3.19M)(6.59M)(8.59M)(15.03M)
Link to MarketWatch's Slice.